source
- FDA approves Regeneron’s Otarmeni gene therapy for rare inherited hearing lossThe FDA has approved Otarmeni, a gene therapy from Regeneron, marking the first therapy cleared under the agency’s national priority voucher program and will be provided to eligible patients at no…
- AbbVie to invest $1.4 billion in new 185-acre manufacturing campus in Durham, North CarolinaAbbVie announced a $1.4 billion investment to build a large manufacturing campus in Durham, North Carolina. The 185-acre site will focus on producing small-volume parenteral medicines such as vial…